Simultaneously, TGF-β exerts systemic immune suppression and inhibits host immunosurveillance and also regulates the infiltration of inflammatory/immune cells and cancer-associated fibroblasts in the TME, causing direct changes in tumor cells (Yang et al., 2010). This evidence concerns the gene TGFB1 and cancer.